FR2393579A1 - Agent antiviral et son application au traitement des affections virales - Google Patents
Agent antiviral et son application au traitement des affections viralesInfo
- Publication number
- FR2393579A1 FR2393579A1 FR787816958A FR7816958A FR2393579A1 FR 2393579 A1 FR2393579 A1 FR 2393579A1 FR 787816958 A FR787816958 A FR 787816958A FR 7816958 A FR7816958 A FR 7816958A FR 2393579 A1 FR2393579 A1 FR 2393579A1
- Authority
- FR
- France
- Prior art keywords
- treatment
- antiviral agent
- application
- viral disorders
- viral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003443 antiviral agent Substances 0.000 title abstract 2
- 230000003612 virological effect Effects 0.000 title abstract 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 241000251468 Actinopterygii Species 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
Cet agent antiviral pour la prévention thérapeutique et le traitement d'une maladie virale chez les animaux à sang chaud, y compris chez l'homme, et chez les poissons, contient, comme ingrédient actif, une quantité antiviralement efficace d'au moins un dérivé de glycine de formule générale:
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6573977A JPS542336A (en) | 1977-06-06 | 1977-06-06 | Preventive and remedy for viral diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2393579A1 true FR2393579A1 (fr) | 1979-01-05 |
FR2393579B1 FR2393579B1 (fr) | 1980-06-13 |
Family
ID=13295678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR787816958A Granted FR2393579A1 (fr) | 1977-06-06 | 1978-05-31 | Agent antiviral et son application au traitement des affections virales |
Country Status (6)
Country | Link |
---|---|
US (1) | US4216226A (fr) |
JP (1) | JPS542336A (fr) |
CA (1) | CA1098827A (fr) |
DE (1) | DE2823346C2 (fr) |
FR (1) | FR2393579A1 (fr) |
GB (1) | GB1599612A (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2377197A1 (fr) * | 1977-01-13 | 1978-08-11 | Hoffmann La Roche | Procede de diagnostic pour detecter un defaut d'absorption des acides amines, des sucres, des graisses, des vitamines et des sels mineraux |
EP0009728A1 (fr) * | 1978-09-23 | 1980-04-16 | Hokuriku Pharmaceutical Co.,Ltd | Agent hémostatique et augmentant les plaquettes sanguines, contenant l'acide alpha-bêta-diaminopropionique et ses dérivés |
EP0313094A2 (fr) * | 1987-10-22 | 1989-04-26 | Meiji Seika Kaisha Ltd. | Médicament anticancéreux et réactif pour l'obtention des revertants |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2941384A1 (de) * | 1979-10-12 | 1981-04-23 | Bayer Ag, 5090 Leverkusen | Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE19843222A1 (de) * | 1998-09-22 | 2000-03-30 | Hassan Jomaa | Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen |
EP1281767A3 (fr) * | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Microbes et cellules lumineuses pour le diagnostic et le traitement des tumeurs |
DE602004018927D1 (de) | 2003-06-18 | 2009-02-26 | Genelux Corp | Modifizierte rekombinante vacciniaviren, verwendungen davon |
US8052968B2 (en) | 2006-10-16 | 2011-11-08 | Genelux Corporation | Modified vaccinia virus strains for use in diagnostic and therapeutic methods |
EP2171071B1 (fr) * | 2007-06-15 | 2015-08-05 | Genelux Corporation | Microorganismes pour une imagerie et/ou un traitement de tumeurs |
EA201301173A1 (ru) | 2011-04-15 | 2015-08-31 | Дженелюкс Корпорейшн | Клональные штаммы аттенуированных вакцинирующих вирусов и способы их использования |
-
1977
- 1977-06-06 JP JP6573977A patent/JPS542336A/ja active Pending
-
1978
- 1978-05-18 GB GB20516/78A patent/GB1599612A/en not_active Expired
- 1978-05-29 DE DE2823346A patent/DE2823346C2/de not_active Expired
- 1978-05-30 US US05/910,627 patent/US4216226A/en not_active Expired - Lifetime
- 1978-05-31 FR FR787816958A patent/FR2393579A1/fr active Granted
- 1978-06-05 CA CA304,750A patent/CA1098827A/fr not_active Expired
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2377197A1 (fr) * | 1977-01-13 | 1978-08-11 | Hoffmann La Roche | Procede de diagnostic pour detecter un defaut d'absorption des acides amines, des sucres, des graisses, des vitamines et des sels mineraux |
EP0009728A1 (fr) * | 1978-09-23 | 1980-04-16 | Hokuriku Pharmaceutical Co.,Ltd | Agent hémostatique et augmentant les plaquettes sanguines, contenant l'acide alpha-bêta-diaminopropionique et ses dérivés |
EP0313094A2 (fr) * | 1987-10-22 | 1989-04-26 | Meiji Seika Kaisha Ltd. | Médicament anticancéreux et réactif pour l'obtention des revertants |
EP0313094A3 (en) * | 1987-10-22 | 1990-08-29 | Meiji Seika Kaisha Ltd. | Anticancer agent and reagent for obtaining revertants |
Also Published As
Publication number | Publication date |
---|---|
DE2823346A1 (de) | 1978-12-14 |
DE2823346C2 (de) | 1985-04-11 |
FR2393579B1 (fr) | 1980-06-13 |
CA1098827A (fr) | 1981-04-07 |
US4216226A (en) | 1980-08-05 |
JPS542336A (en) | 1979-01-09 |
GB1599612A (en) | 1981-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA27121A1 (fr) | Derives 2-(purin-9-yl)-tetrahydrofuran-3,4-diol | |
MA27156A1 (fr) | NUCLEOSIDES 3- β-D-RIBOFURANOSYLTHIAZOLO[4,5-d] PYRIDIMINE ET LES UTILISATIONS DE CELLES-CI | |
ATE219363T1 (de) | Lösliche prodrugs von paclitaxel | |
TNSN97091A1 (fr) | CONJUGUE PEG-IFN α PHYSIOLOGIQUEMENT ACTIF, PROCEDE POUR SA PREPARATION, COMPOSITIONS PHARMACEUTIQUES LE CONTENANT ET LEUR UTILISATION | |
HUT67436A (en) | Process to prepare novel hydroxamic acid and n-hydroxyurea derivatives and pharmaceutical compn.s contg. them | |
FR2434155A1 (fr) | Derives d'imidazole et leur utilisation pour le traitement des maladies provoquees par le thromboxane a2 | |
DK162883D0 (da) | N-glucosylerede carboxylsyreamidderivater, fremgangsmade til fremstilling heraf samt deres anvendelse til pavirkning af organismens egen forsvarsmekanisme | |
DE69526353D1 (de) | Immunologische aktivität der rhamnolipide | |
FR2361901A1 (fr) | Derives de substitution de nucleotides et medicament contenant ces substances | |
FR2393579A1 (fr) | Agent antiviral et son application au traitement des affections virales | |
DE4394931T1 (de) | Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen | |
FR2354324A1 (fr) | Nouveaux composes triazoliques, leur procede de preparation et leurs applications au traitement de plantes | |
FR2387988A1 (fr) | Esters de cefuroxime, leur preparation et leur application therapeutique | |
FR2430418A1 (fr) | Derives halogenomethyles d'a-aminoacides, leur preparation et leurs utilisations therapeutiques | |
TNSN90021A1 (fr) | Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales | |
FR2405067A1 (fr) | Compositions pharmaceutiques contenant des derives monofonctionnels du psoralene pour le traitement des affections cutanees | |
FR2445329A1 (fr) | Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament | |
FR2420344A1 (fr) | Nouveaux oxime-ethers, leur preparation et leur application therapeutique. | |
FR2405657A1 (fr) | Agent favorisant la croissance des animaux | |
FR2362587A1 (fr) | Agents antimicrobie | |
FR2428436A1 (fr) | Nouvelles compositions cosmetiques pour le traitement de l'etat gras des cheveux et de la peau, composes nouveaux et leur procede de preparation | |
FR2369837A1 (fr) | Derives actifs de l'uree, leur procede de preparation ainsi que les compositions therapeutiques les contenant | |
ATE110714T1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
FR2433943A1 (fr) | Preparations medicamenteuses notamment pour le traitement de l'hypercholesterolemie | |
FR2355846A1 (fr) | Esters de penicillines utilisables comme medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |